ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Diabetes and endocrinology · Diabetes Care · 2026-03-01

Meta-analysis of 20 RCTs (83,288 participants with type 2 diabetes or cardiometabolic disease): GLP-1 receptor agonists were not associated with a higher risk of optic nerve or vision-threatening events (OR 1.20, 95% CI 0.73-1.97).

Meta-analysisn = 83,288
Li et al. GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.